肿瘤学II期试验中通过广义信息准则的频率学方法识别有效篮式亚型
针对分子靶向肿瘤药物需在多个肿瘤类型中同时评估的需求,本文指出既往篮式试验中广义信息准则(GIC)的缺陷,并提出改进的GIC。新GIC更有效借用篮子间信息,数值研究显示其优于原方法。
要点
- 提出改进的广义信息准则用于频率学框架下识别有效篮子。
- 新GIC克服原GIC不良特征,更有效借用跨篮子信息。
- 数值研究证明新GIC性能优于原GIC。
核心结论
- 新GIC克服原GIC不良特征,更有效借用篮子间信息,数值研究显示优于原GIC。
研究设计与样本
- 方法学研究,基于单样本Mantel-Haenszel程序,包含全局零假设精确检验、Mantel-Haenszel型疗效估计及通过GIC识别有效篮子。
主要发现
- 指出既往研究中GIC存在不良特征,并提出替代GIC。
- 新GIC无该不良特征且更有效借用篮子间信息。
- 数值研究表明新GIC优于原GIC。
临床怎么用
- 在肿瘤学II期篮式试验中,可采用新GIC识别有效篮子,实现频率学框架下的多亚型同时评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many molecular-targeted oncology drugs have been successfully developed. The mechanism to target some specific molecules gives us the expectation that the molecular-target drug is effective over multiple tumor types and histologies. Then, simultaneous evaluation of multiple subtypes is motivated, and the basket trials aim to realize it, in which each subtype is called a basket. Although the single-arm design with simple exact binomial inference is routinely used for Phase 2 trials in standard oncology drug development, almost all recent proposals of statistical methods for basket trials are Bayesian methods of complexity. To fill the gap, the one-sample Mantel-Haenszel procedure was developed, which consists of the exact test of the global null hypothesis, the Mantel-Haenszel-type estimation of the treatment effect, and identification of effective baskets via the generalized information criterion (GIC). This paper points out an undesirable feature of the GIC in the previous research and develops an alternative one. The new GIC is free of the undesirable feature and more efficiently borrows information across baskets, which is a relevant feature for basket trials. Through numerical studies, we demonstrate that the new GIC outperforms the original one.
引用
- Tanaka S, Ohara R, Hattori S, et al. Frequentist Identification of Effective Baskets via the Generalized Information Criteria in Oncology Phase 2 Trials. Stat Med. 2026. PMID: 42446164. doi:10.1002/sim.70673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。